Related Experiment Video
Updated: Oct 25, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and
Chinnadurai Mani1, Kaushlendra Tripathi2, Sandeep Chaudhary3
1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Abstract:
Ovarian cancer (OC) is one of the most lethal type of cancer in women due to a lack of effective targeted therapies and high rates of treatment resistance and disease recurrence. Recently Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown promise as chemotherapeutic agents; however, their efficacy is limited to a small fraction of patients with BRCA mutations. Here we show a novel function for the Hedgehog (Hh) transcription factor Glioma associated protein 1 (GLI1) in regulation of key Fanconi anemia (FA) gene, FANCD2 in OC cells. GLI1 inhibition in HR-proficient OC cells induces HR deficiency (BRCAness), replication stress and synergistic lethality when combined with PARP inhibition. Treatment of OC cells with combination of GLI1 and PARP inhibitors shows enhanced DNA damage, synergy in cytotoxicity, and strong in vivo anticancer responses.
Insights
This study reveals a new role for GLI1 in ovarian cancer, showing that inhibiting it can make cancer cells more sensitive to PARP inhibitors by increasing DNA damage and improving treatment response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer (OC) is a lethal malignancy with limited targeted therapies and frequent recurrence.
- Poly (ADP-ribose) polymerase inhibitors (PARPi) show efficacy but are limited to patients with BRCA mutations.
Purpose of the Study:
- To investigate the role of Hedgehog (Hh) transcription factor Glioma associated protein 1 (GLI1) in ovarian cancer.
- To explore the potential of GLI1 inhibition in combination with PARP inhibitors for OC treatment.
Main Methods:
- Investigated GLI1 regulation of the FANCD2 gene in OC cells.
- Assessed the effects of GLI1 inhibition on homologous recombination (HR) proficiency, replication stress, and cell viability.
- Evaluated the synergistic effects of combined GLI1 and PARP inhibition on DNA damage, cytotoxicity, and in vivo anticancer responses.
Main Results:
- GLI1 inhibition in HR-proficient OC cells induced HR deficiency (BRCAness) and replication stress.
- Combination therapy of GLI1 and PARP inhibitors demonstrated synergistic lethality in OC cells.
- Combined treatment enhanced DNA damage, cytotoxicity, and showed significant in vivo anticancer activity.
Conclusions:
- GLI1 plays a novel regulatory role in DNA repair pathways in ovarian cancer.
- Targeting GLI1 in combination with PARP inhibitors offers a promising therapeutic strategy for ovarian cancer, potentially expanding treatment options beyond BRCA-mutated cases.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
04:07Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Related Concept Videos
Hedgehog Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation